Study Analyzes Drugs For Diabetes- Attention Infection Announcement

by Kathaleen
in misc.

18, 2015 Copyright © 2015 HealthDay .

Small Study Links Lack of Sleep to Type 2 Diabetes Risk news

19 in the journal Diabetologia. The findings add to growing evidence that lack of sleep may disrupt fat metabolism, and suggest that increasing people's amount of sleep may reduce rates of obesity and diabetes, the researchers said. More information The U.S. Centers for Disease Control and Prevention has more about sleep . SOURCE: University of Chicago Medical Center, news release, Feb.

Minority Kids Less Likely to Get Latest Type 1 Diabetes Care, Study Finds news

They're absolutely gone. It's a fantastic drug, as far as I'm concerned." Up to now, the main treatment for diabetic retinopathy involved using lasers to essentially burn away tissue at the edges of the retinas, Dugel said.

Smoking During Pregnancy May Raise Diabetes Risk for Daughters: Study news

"But we still need to research why these early deaths are happening." More information For more on type 1 diabetes, visit the American Diabetes Association .

Blood Pressure Meds Lower Heart, Stroke Risks in Diabetics: Analysis news

Food and Drug Administration. Lucentis (ranibizumab) has been sanctioned to treat diabetic retinopathy, the leading cause of blindness among adults in the United States, the FDA said in a news release. In 2008, one-third of diabetic adults 40 or older had some form of diabetic retinopathy, the agency said. Lucentis, a once-monthly injection, is designed to be used with other therapies to control blood sugar, blood pressure and cholesterol, the FDA said. In some people with diabetic retinopathy who also have diabetic macular edema, abnormal blood vessels can grow and rupture on the eye's retina, leading to severe vision loss or blindness.

Lucentis Approved for Diabetic Retinopathy news

Nearly two-thirds of white youngsters were on insulin pumps. Just 26 percent of the black children made use of the newer technology, and slightly more than one-third of the Hispanic youngsters used insulin pumps, the researchers found. Cost is undoubtedly one factor considered when thinking about using an insulin pump for managing type 1 diabetes. The actual cost varies based on insurance plans -- or in the case of Medicaid, the coverage offered by a particular state -- but a new pump can be more than $5,000, according to published reports. Additional disposable supplies are needed each month as part of insulin pump management.

FDA Approves 1st Drug for Diabetic Retinopathy news

All the mothers had received obstetric care in the San Francisco area at some point between 1959 and 1967. Because the study was initially launched to explore breast cancer risk, no sons were included in the current analysis. The findings build on prior research suggesting that fetal exposure to cigarettes boosts the risk for both obesity and low birth weight. "Our findings are consistent with the idea that gestational environmental chemical exposures can contribute to the development of health and disease," study author Michelle La Merrill, an assistant professor of environmental toxicology at University of California, Davis, said in a university news release." "We found that smoking of parents is by itself a risk factor for diabetes, independent of obesity or birth weight," she added. According to La Merrill, the study suggests that, "if a parent smokes, you're not protected from diabetes just because you're lean." The study authors found that diabetes risk also seemed to go up among women who had been exposed to smoke in the womb via their father's cigarette habit, though the degree of the rise in risk remains unclear. However, while the study found an association between smoking during pregnancy and diabetes risk in daughters, it could not prove a cause-and-effect link.

Type 1 Diabetes More Deadly for Women Than Men, Study Finds news

Williams, who wrote a commentary accompanying the review, added: "If I was a younger diabetic, I would certainly want my blood pressure well controlled, always below 140/90 mm Hg and below 130/80 mm Hg if possible. As patients get older, they sometimes tolerate such aggressive treatment less well, but it is worth trying to reach a level of blood pressure that is as low as tolerated without symptoms." What's next? Rahimi said he expects the study will change how doctors treat patients with diabetes, especially because the review didn't show signs of harm from the blood pressure medications. Still, the research showed that the positive effect of the drugs was smaller in diabetics with lower blood pressure levels. "For a small group of diabetic people," he said, "this could mean that the expected benefit of blood pressure-lowering may not be large enough for them to take blood pressure-lowering tablets." The study was published in the Feb.

About me